About Foundation for Innovative New Diagnostics India
Data last updated:
Foundation for Innovative New Diagnostics India is a private not for profit company based in New Delhi, Delhi, India. It operates in the research and development sector. It was incorporated on 07 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL2015NPL282471. Its GSTIN is 07AACCF6112D1Z6 (Delhi).
It is led by directors Vishal Chandrakant Negandhi and Rashmi Vishal Negandhi.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 8 9th Floor Vijaya Building 17 Barakhamba Road, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.75 Cr, a decline of 80% compared to the previous year. For the same year it recorded a net profit of ₹43.09 Lakh (net margin 1.8%) and EBITDA of ₹61.84 Lakh (EBITDA margin 2.6%). Revenue has declined at a compounded annual rate (CAGR) of 46% over three years and 21% over five years.
The company has about 97 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: FIND Diagnostics. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website finddx.org.
Company details
Contact details
Foundation for Innovative New Diagnostics India's registered office is in New Delhi, Delhi. Its website is finddx.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No. 8 9th Floor Vijaya Building 17 Barakhamba Road, New Delhi, Delhi, India – 110001
- IndustryResearch & Development, Research & Development
To see the full contact details of Foundation for Innovative New Diagnostics India, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Foundation for Innovative New Diagnostics India operates one associated brand: FIND Diagnostics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Diagnostic tests for poverty-related diseases | finddx.org |
Business activity
The main business activity of Foundation for Innovative New Diagnostics India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
Financials of Foundation for Innovative New Diagnostics India
FY 2025 filings availableFoundation for Innovative New Diagnostics India reported revenue of ₹23.75 Cr (down 80% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 21% over five years, including a 80% fall in the latest year. EBITDA rose 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹43.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Foundation for Innovative New Diagnostics India, buy the company report.
Board of directors of Foundation for Innovative New Diagnostics India
Foundation for Innovative New Diagnostics India has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Chandrakant Negandhi | Director | 08 Oct 2024 | 2 Years 0 Months | Current |
| Rashmi Vishal Negandhi Also directs: Induscircle Corporate & Trustee Services LLP, Dreamcorn Ventures India LLP, Unitas Global India Private Limited and 5 more | Director | 08 Oct 2024 | 2 Years 0 Months | Current |
Peer comparison
Foundation for Innovative New Diagnostics India is compared with the 9 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Orchid Scientific & Innovative India Private Limited | ₹24.22 Cr (FY 2024) | -45.0% | Nashik, Maharashtra, India | |||
| Cellworks Research India Private Limited | ₹23.98 Cr (FY 2024) | 15.0% | Bangalore, Karnataka, India | |||
| Csep Research Foundation | ₹23.95 Cr (FY 2025) | -11.0% | New Delhi, Delhi, India | |||
| Atgc Biotech Private Limited | ₹23.77 Cr (FY 2024) | 58.0% | Hyderabad, Telangana, India | |||
| Foundation for Innovative New Diagnostics Indiathis company | ₹23.75 Cr (FY 2025) | ₹43.09 Lakh | 1.8% | -80.0% | 97 | New Delhi, Delhi, India |
| Pharmascroll Research and Consulting Private Limited | ₹23.68 Cr (FY 2025) | 70.0% | Hyderabad, Telangana, India | |||
| Appcure Labs Private Limited | ₹23.08 Cr (FY 2025) | 41.0% | Hyderabad, Telangana, India | |||
| Sanjay Knit Private Limited | ₹23.05 Cr (FY 2024) | 0.0% | Pune, Maharashtra, India | |||
| SMD Systems Private Limited | ₹22.83 Cr (FY 2025) | 36.0% | Mumbai, Maharashtra, India | |||
| Nmicps Technology Innovation Hub On Autonomous Navigation Foundation | ₹22.75 Cr (FY 2025) | 109.0% | Kandi, Telangana, India |
To see the full peer comparison of Foundation for Innovative New Diagnostics India, buy the company report.
Auditor
Foundation for Innovative New Diagnostics India is audited by BSR and Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BSR and Co | FY 2023 | 128510W |
Shareholding
The shareholding of Foundation for Innovative New Diagnostics India is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions and public shareholders.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public |
To see the full shareholding pattern of Foundation for Innovative New Diagnostics India, buy the company report.
Legal cases
Foundation for Innovative New Diagnostics India has 1 court case on record: 1 filed by Foundation for Innovative New Diagnostics India. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| Supreme Court | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case | Filed by the company against Union of India | Disposed |
To see the full case history of Foundation for Innovative New Diagnostics India, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Foundation for Innovative New Diagnostics India has 10 MSME Form 1 returns on record between 2019 and 2023, listing 40 overdue payments to 16 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 16)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Chembio Lifesciences | |||
| Gravity Solution | |||
| an individual supplier |
To see the full MSME payment records of Foundation for Innovative New Diagnostics India, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Foundation for Innovative New Diagnostics India has a workforce of 97 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
GST
Foundation for Innovative New Diagnostics India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCF6112D1Z6 | Delhi | Active | 10 Nov 2023 |
To see the full GST registrations and return filing status of Foundation for Innovative New Diagnostics India, buy the company report.
Recent activity
Foundation for Innovative New Diagnostics India has 9 board changes on record since 2016: 2 appointments and 7 cessations. The latest: Rashmi Vishal Negandhi ceased to be Additional Director on 14 Oct 2024.
News
Frequently asked questions
Foundation for Innovative New Diagnostics India is an active private not for profit company based in New Delhi, Delhi, India. The company works in the research and development industry. It was incorporated on 07 July 2015 (11+ years old) and is registered under CIN U73100DL2015NPL282471.
Foundation for Innovative New Diagnostics India has 2 current directors:
- Vishal Chandrakant Negandhi - Director
- Rashmi Vishal Negandhi - Director
The latest financial statements of Foundation for Innovative New Diagnostics India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Foundation for Innovative New Diagnostics India is 07AACCF6112D1Z6, registered in Delhi.
The CIN (Corporate Identification Number) of Foundation for Innovative New Diagnostics India is U73100DL2015NPL282471. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Foundation for Innovative New Diagnostics India has 1 court case on record: 1 filed by the company.
Foundation for Innovative New Diagnostics India was incorporated on 07 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Foundation for Innovative New Diagnostics India by revenue are Orchid Scientific & Innovative India Private Limited, Cellworks Research India Private Limited, Csep Research Foundation, Atgc Biotech Private Limited, Pharmascroll Research and Consulting Private Limited and 4 more, all in the same principal business activity (scientific research and development).
Rashmi Vishal Negandhi ceased to be Additional Director on 14 Oct 2024. Vishal Chandrakant Negandhi ceased to be Additional Director on 14 Oct 2024. Paramasivan Chinnambedu Nainarappan ceased to be Director on 08 Oct 2024. Foundation for Innovative New Diagnostics India has 9 board changes on record in total.
Foundation for Innovative New Diagnostics India has 10 MSME Form 1 returns on record between 2019 and 2023, listing 40 overdue payments to 16 micro and small suppliers. The latest return was filed on 31 Aug 2023.
Foundation for Innovative New Diagnostics India can be reached through the website finddx.org. Its registered office is in New Delhi, Delhi, India.
The registered office of Foundation for Innovative New Diagnostics India is at Flat No. 8 9th Floor Vijaya Building 17 Barakhamba Road, New Delhi, Delhi, India – 110001.